BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Science '22 in Review
Top Biopharma Trends of 2022
Top Med-tech Trends of 2022
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, November 30, 2023
See today's BioWorld
Home
» Other news to note for March 15, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for March 15, 2021
March 15, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Aeterna Zentaris, Altimmune, Amring, Amzell, Aveo, Astrazeneca, Biovaxys, Bright Minds, Decipher, Destiny, Genevant, Gilead, Horizon, J&J, Lattice, Magenta, Merck, Mersana, Newron, Point, PTC, Resverlogix, Takeda, Tevogen, Timber, Urogen, Veracyte, Viela, Wuxi, Zambon.
BioWorld
Briefs
Other news to note
Coronavirus